{{Rsnum
|rsid=3753242
|Gene=PRKCZ
|Chromosome=1
|position=2138242
|Orientation=plus
|GMAF=0.2043
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PRKCZ
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 92.0 | 7.1 | 0.9
| HCB | 23.4 | 46.7 | 29.9
| JPT | 5.3 | 52.2 | 42.5
| YRI | 96.5 | 3.5 | 0.0
| ASW | 91.1 | 8.9 | 0.0
| CHB | 23.4 | 46.7 | 29.9
| CHD | 20.2 | 44.0 | 35.8
| GIH | 61.4 | 34.7 | 4.0
| LWK | 97.3 | 2.7 | 0.0
| MEX | 72.4 | 25.9 | 1.7
| MKK | 0.0 | 0.0 | 0.0
| TSI | 82.4 | 16.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=0.000001
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID|18615853}} Genetic variants in protein kinase C zeta gene and type 2 diabetes risk: a case-control study of a Chinese Han population.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}